Synapse - Martin Fleisher

Results (312)

Risk-adapted intravenous melphalan with adjuvant thalidomide and dexamethasone for newly diagnosed untreated patients with systemic AL amyloidosis: Interim report of a phase II trial

Conference Paper

Comenzo, R. L.; Zhou, P.; Reich, L.; Costello, S.; Quinn, A.; Fircanis, S.; Drake, L.; Hedvat, C.; Teruya-Feldstein, J.; Filippa, D. A.; more...
CRC Press (2004)

Fulltext@MSK | Save

Frequency of molecular and PET/CT complete remissions in patients with multiple myeloma after autologous followed by reduced-intensity allogeneic stem cell transplants

Meeting Abstract

Zhou, P.; Castro-Malaspina, H.; Papadopoulos, E. B.; Young, J. W.; Miller, K.; Pandit-Taskar, N.; Filippa, D. A.; Fleisher, M.; Comenzo, R. L.
Blood (2004)

Fulltext@MSK | Save

Low bone mass in thalassemia: The thalassemia clinical research network (TCRN) experience

Meeting Abstract

Vogiatzi, M. G.; Lane, J.; Fleisher, M.; Macklin, E. A.; Fung, E. B.; Kirby, M.; Kwiatkowski, J.; Holm, I.; Olivieri, N.; Vichinsky, E.; more...
Blood (2004)

Fulltext@MSK | Save

Prospective analysis of expression of YKL-40 in the serum of patients with glioblastoma multiforme

Meeting Abstract

Hormigo, A.; Gu, B.; Fleisher, M.; Deangelis, L. M.; Holland, E. C.
Neuro-Oncology (2004)

Fulltext@MSK | Save

Doxorubicin and dexamethasone followed by thalidomide and dexamethasone (AD-TD) as initial therapy for symptomatic patients with multiple myeloma

Meeting Abstract

Hassoun, H.; Reich, L.; Klimek, V. M.; Kewalramani, T.; Dhodapkar, M.; Drake, L.; Zimman, R.; Hedvat, C. V.; Teruya-Feldstein, J.; Fleisher, M.; more...
Blood (2004)

Fulltext@MSK | Save

Risk-adapted intravenous melphalan followed by adjuvant dexamethasone (D) and thalidomide (T) for newly diagnosed patients with systemic AL amyloidosis (AL): Interim results of a phase II study